Improving covalent cell encapsulation with temporarily reactive polyelectrolytes
Tóm tắt
Calcium alginate/poly-l-lysine beads were coated with either 50% hydrolyzed poly(methyl vinyl ether–alt–maleic anhydride) (PMM50), or with poly(vinyl dimethyl azlactone-co-methacrylic acid) (50:50, PMV50), to form covalently shell-crosslinked capsules, and compared with analogous capsules coated with sodium alginate. All capsule types were prepared with and without C2C12 murine myoblast cells, and implanted into mice for up to 6 weeks. Cell viability, capsule integrity, fibrotic overgrowth, and mechanical strength of the capsules were assessed, and correlated with inflammatory cytokine marker levels in tail vein blood samples taken at different time points. AP-PMM50 capsules displayed the least amount of fibrotic overgrowth, were found to be the strongest, and showed the lowest levels of TNF-α in tail vein serum samples taken at 4 h, 24 h, 1 and 6 weeks post transplantation. The results for APA and AP-PMV50 capsules were more variable and depended on the presence or absence of encapsulated cells.
Tài liệu tham khảo
Zimmermann H, Shirley S, Zimmermann U. Alginate-based encapsulation of cells: past, present, and future. Curr Diab Rep. 2007;7:314–20.
De Vos P, Faas MM, Strand B, Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials. 2006;27:5603–17.
Poncea S, Orive G, Hernandez R, Gascon AR, Pedraza JL, de Haan BJ, Marijke Faas MM, Mathieu HJ, de Vos P. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials. 2006;27:4831–9.
Wilson JT, Chaikov EL. Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Delivery Rev. 2008;60:124–45.
De Castro M, Orive G, Hernández RM, Gascón AR, Pedraz JL. Comparative study of microcapsules elaborated with three polycations (PLL, PDL, PLO) for cell immobilization. J Microencapsul. 2005;22:303–15.
Peirone MA, Delaney K, Kwiecin J, Fletch A, Chang PL. Delivery of recombinant gene product to canines with nonautologous microencapsulated cells. Hum Gene Ther. 1998;9:195–206.
Zimmermann H, Zimmermann D, Reuss R, Feilen PJ, Manz B, Katsen A, Weber M, Ihmig FR, Ehrhart F, Gebner P, Behringer M, Sterinback A, Wegner LH, Sukhorukov VL, Vasquez JA, Schneider S, Weber MM, Volke F, Wolf R, Zimmermann U. Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci Mater Med. 2005;16:491–501.
Dusseault J, Tam SK, Ménard M, Polizu S, Jourdan G, Yahia L, Hallé JP. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J Biomed Mater Res Part A. 2006;75A:243–51.
Orive G, Tam SK, Pedraz JL, Hallé JP. Biocompatibility of alginate poly-l-lysine microcapsules for cell therapy. Biomaterials. 2006;27:3691–700.
Fan MY, Lum ZP, Fu XW, Levesque L, Tai IT, Sun AM. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets. Diabetes. 1990;39:519–22.
Goosen MFA, O'Shea GM, Charapetian HM, Chou S, Sun AM. Optimization of microencapsulation parameters: semipermeable microcapsules as a bioartifical pancreas. Biotechnol Bioeng. 1984;27:146–50.
Holme HK, Davidsen L, Kristiansen A, Smidsrød O. Kinetics and mechanisms of depolymerisation of alginate and chitosan in aqueous solution. Carbohydr Polym. 2008;73:656–64.
Rokstad AM, Donati I, Borgogna M, Oberholzer J, Strand BL, Espevik T, Skjåk-Bræk G. Cell-compatible covalently reinforced beads obtained from a chemoenzymatically engineered alginate. Biomaterials. 2006;27:4726–37.
Cellesi F, Tirelli N, Hubbell JA. Materials for cell encapsulation via a new tandem approach combining reverse thermal gelation and covalent crosslinking. Macromol Chem Phys. 2002;203:1466–72.
Lu MZ, Lan HL, Wang FF, Chang SJ, Wang YJ. Cell encapsulation with alginate and α-phenoxycinnamylidene-acetylated poly(allylamine). Biotechnol Bioeng. 2000;70:479–83.
Wang YJ. Development of new polycations for cell encapsulation with alginate. Mat Sci Eng C. 2000;13:59–63.
Dusseault J, Leblond FA, Robitaille R, Jourdan G, Tessier J, Ménard M, Henley N, Halle JP. Microencapsulation of living cells in semi-permeable membranes with covalently cross-linked layers. Biomaterials. 2005;26:1515–22.
Vermonden T, Fedorovich NE, van Geemen D, Alblas J, van Nostrum CF, Dhert WJA, Hennink WE. Photopolymerized thermosensitive hydrogels: synthesis, degradation, and cytocompatibility. Biomacromolecules. 2008;9:919–26.
Gardner CM, Burke NAD, Stover HDH. Cross-linked microcapsules formed from self-deactivating reactive polyelectrolytes. Langmuir. 2010;26:4916–24.
Lin C-C, Metters AT, Anseth KS. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatroy cytokine TNFα. Biomaterials. 2009;30:4907–14.
Su J, Hu B-H, Lowe WL Jr, Kaufman DB, Messersmith PB. Anti-inflammatory peptide-functionalized hydrogel for insulin-secreting cell encapsulation. Biomaterials. 2010;31:308–14.
Gardner CM, Stover HDH. Synthesis and characterization of reactive polyanions based on poly(vinyl dimethyl azlactone-co-methacrylic acid). Macromolecules. 2011;44:7115–23.
Li AA, McDonald NC, Chang PL. Effect of growth factors and extracellular matrix materials on the proliferation and differentiation of microencapsulated myoblasts. J Biomater Sci Polym Ed. 2003;14:533–49.
Sun AM. Microencapsulation of pancreatic islet cells: a bioartificial endocrine pancreas. Methods Enzymol. 1988;137:575–80.
Shen F, Mazumder MAJ, Burke NAD, Stöver DHH, Potter MA. Mechanically enhanced microcapsules for cellular gene therapy. J Biomed Mater Res B Appl Biomater. 2009;90B:350–61.
Shen F, Li AA, Gong Y-K, Somers S, Potter MA, Winnik FM, Chang PL. Encapsulation of recombinant cells with a novel magnetized alginate for magnetic resonance imaging. Hum Gene Ther. 2005;16:971–84.
Fritschy WM, deVos R, Groen H, Klatter FA, Pasma A, Wolters GHJ, van Schilfgaarde R. The capsular overgrowth on microencapsulated pancreatic islet grafts in streptozotocin and autoimmune diabetic rats. Transpl Int. 1994;7:264–71.
Langlois G, Dusseault J, Bilodeau S, Tam SK, Magassouba D, Hallé JP. Direct effect of alginate purification on the survival of islets immobilized in alginate-based microcapsules. Acta Biomater. 2009;5:3433–40.
Wijsman J, Atkison P, Mazaheri R, Garcia B, Paul T, Vose J, O'Shea G, Stiller C. Histological and Immunopathological analysis of recovered encapsulated allogenic islets from transplanted diabetic BB/w rats. Transplantation. 1992;54:588–92.
Isfahani ZG. In vivo characterization of murine innate immune response to alginate-poly-l-lysine-alginate Microcapsules. Thesis, (MSc). McMaster University.
King A, Sandler S, Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J Biomed Mater Res. 2001;57:374–83.
Cole DR, Waterfall M, McIntyre M, Baird JD. Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia. 1992;35:231–7.
Thomas A, Harding KG, Moore K. Alginates from wound dressings activates human macrophages to secrete tumour necreosis factor-α. Biomaterials. 2000;21:1797–802.
Otterlei M, Sundan A, Skajåk-Bræk G, Ryan L, Smidsrod O, Espevik T. Similar mechanisms of action of defined polysacchardies and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect Immun. 1993;61:1917–25.
Robitaille R, Dusseault J, Henely N, Desbien K, Labrecque N, Hallé JP. Inflammatory response to peritoneal implantation of alginate-poly-l-lysine microcapsules. Biomaterials. 2005;26:4119–27.
Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P, Kunkel SL. Role of monocyte chemoatractant protein-1 (MCP-1) in Th1 (Mycobacterial) and TH2 (Schistosomal) antigen-induced granuloma formation. J Immunol. 1996;157:4602–8.
Li AA, Shen F, Zhang T, Cirone P, Potter MA, Chang PL. Enhancement of myoblast microencapsulation for gene therapy. J Biomed Mater Res Part B. 2006;77:296–306.